Dark Forest Capital Management LP Makes New $596,000 Investment in ICU Medical, Inc. (NASDAQ:ICUI)

Dark Forest Capital Management LP purchased a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,844 shares of the medical instruments supplier's stock, valued at approximately $596,000.

Several other hedge funds also recently bought and sold shares of the stock. Massar Capital Management LP purchased a new position in ICU Medical during the fourth quarter worth $532,000. Hsbc Holdings PLC boosted its holdings in shares of ICU Medical by 12.1% during the fourth quarter. Hsbc Holdings PLC now owns 5,707 shares of the medical instruments supplier's stock worth $886,000 after purchasing an additional 618 shares during the last quarter. State of Tennessee Department of Treasury boosted its holdings in shares of ICU Medical by 9.4% during the fourth quarter. State of Tennessee Department of Treasury now owns 12,378 shares of the medical instruments supplier's stock worth $1,921,000 after purchasing an additional 1,067 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of ICU Medical by 87.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 1,352 shares of the medical instruments supplier's stock worth $210,000 after purchasing an additional 632 shares during the last quarter. Finally, MetLife Investment Management LLC boosted its holdings in shares of ICU Medical by 4.5% during the fourth quarter. MetLife Investment Management LLC now owns 12,946 shares of the medical instruments supplier's stock worth $2,009,000 after purchasing an additional 557 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Raymond James set a $97.00 price objective on ICU Medical in a research note on Wednesday, March 12th. KeyCorp lowered their price objective on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Finally, StockNews.com downgraded shares of ICU Medical from a "buy" rating to a "hold" rating in a research report on Thursday. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $162.67.

ICU Medical Stock Performance

ICU Medical stock traded up $0.24 during mid-day trading on Monday, reaching $135.90. The company's stock had a trading volume of 297,693 shares, compared to its average volume of 274,101. The firm has a market cap of $3.34 billion, a price-to-earnings ratio of -29.74 and a beta of 0.86. The business has a 50 day moving average price of $143.25 and a 200-day moving average price of $157.64. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a twelve month low of $95.44 and a twelve month high of $196.26.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.